Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Best Practice & Research. Clinical Gastroenterology|June 11, 2014
Not all monoclonals are created equal - lessons from failed drug trials in Crohn's diseaseArthur KaserExpert Opinion on Therapeutic Targets|April 16, 2008
Novel therapeutic targets in the treatment of IBDArthur Kaser, Herbert TilgExpert Opinion on Biological Therapy|October 22, 2002
Antitumour necrosis factor therapy in Crohn's diseaseHerbert Tilg, Arthur KaserExpert Opinion on Biological Therapy|April 23, 2004
Type I interferons and their therapeutic role in Th2-regulated inflammatory disordersHerbert Tilg, Arthur KaserThe Journal of Clinical Investigation|June 3, 2011
Gut microbiome, obesity, and metabolic dysfunctionHerbert Tilg, Arthur KaserCurrent Drug Delivery|October 26, 2011
"Metabolic aspects" in inflammatory bowel diseasesArthur Kaser, Herbert TilgCurrent Opinion in Investigational Drugs (London, England : 2000)|December 16, 2010
Vedolizumab, a humanized mAb against the α4β7 integrin for the potential treatment of ulcerative colitis and Crohn's diseaseHerbert Tilg, Arthur KaserExpert Opinion on Therapeutic Targets|February 25, 2009
Inflammatory bowel diseases: highlights from the United European Gastroenterology Week 2008Arthur Kaser, Herbert TilgActa Gastro-Enterologica Belgica|August 25, 2011
Endoplasmic reticulum stress and inflammatory bowel diseaseLukas Niederreiter, Arthur KaserNature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Treatment strategies in nonalcoholic fatty liver diseaseHerbert Tilg, Arthur KaserPageof 16